AstraZeneca

SEP 9, 2026 · PHASE 3 TRIAL

A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is an active clinical trial registry record with no posted results; the study design and planned endpoints are documented but outcome data are not yet reported.

SEP 9, 2026 · OBSERVATIONAL STUDY

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

ClinicalTrials.gov

This is a clinical trial registry record describing a planned observational study with no results posted; it documents study design and intended outcomes only, not evidence of efficacy or safety.

SEP 9, 2026 · OBSERVATIONAL STUDY

TROP2 NMR Concordance Study

ClinicalTrials.gov

This is a registry record for a planned observational study with no results reported; it describes study design and protocol only, making it preliminary evidence documentation rather than evidence of efficacy or safety.

SEP 9, 2026 · PHASE 2 TRIAL

A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy

ClinicalTrials.gov

This is a Phase 2 trial registry record with no results posted; enrollment is complete but outcomes have not yet been reported or analysed.

SEP 8, 2026 · PHASE 2 TRIAL

A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations

ClinicalTrials.gov

Phase 2 interventional trial with planned safety and efficacy endpoints in EGFR-mutant NSCLC; no results reported in this registry record.

SEP 2, 2026 · PHASE 2 TRIAL

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

ClinicalTrials.gov

Phase 2 interventional trial in a serious acute condition with surrogate renal endpoint; results not yet reported in this registry record.

AUG 20, 2026 · PHASE 3 TRIAL

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

ClinicalTrials.gov

This is a Phase 3 trial registration with no reported results; the study is actively recruiting and outcome data are not yet available.

AUG 20, 2026 · PHASE 3 TRIAL

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

ClinicalTrials.gov

This is a registered Phase 3 trial not yet recruiting with no results posted; it describes a planned study design and primary endpoint only.